CHC decreased the level of the inflammatory cytokines IL-1β and IFN-γ in serum, and improved immune status (represented by the levels of IgA and IgM in serum, and SIgA in the mucosa of duodenum and jejunum). The gene discussed is CD79A; the disease is cryohydrocytosis.